Why the numbers work: 2.8% monthly attrition vs 6-8% industry average: lower hidden retraining costs over multi-year engagements 90% CSAT: fewer escalations, fewer repeat contacts, stronger patient experience metrics 5-year average client partnerships: onboarding investment amortizes over a much longer value cycle SOC 2, HIPAA, GDPR, ISO 27001 certified: compliance is built in, not bolted on after contracting
Theyre the perfect pick-me-up for when you hit a plateau or need a little metabolic boost
HbA1c well above target despite oral therapy Insulin or GLP-1 agonist depending on patient preference, weight, and risk profile
At 11.2%, Retatrutide sees slightly more participants stopping treatment compared to Tirzepatides 9.1%
Reactive Oxygen Species (ROS) kit, DAPI and Calcein AM were purchased from Beyotime Biotechnology Corp., Ltd